Review
Jul 2026
Abstract A025: Real-World Data–Driven Target Discovery in Advanced NSCLC
This work demonstrates the novel application and value of multimodal liquid-biopsy RWD for scalable, clinically anchored therapeutic Target ID in solid tumors and indicates a complementary discovery paradigm that accelerates hypothesis generation grounded in patient outcomes.
Aaron Hardin, Peili Zhang, Amar K. Das
· Clinical Cancer Research · 0 citations